Drug Type Small molecule drug |
Synonyms XR-774 |
Target |
Action inhibitors |
Mechanism RTK inhibitors(Receptor protein-tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18O5 |
InChIKeyXAABSYWNTKOZII-SESVDKBCSA-N |
CAS Registry339320-58-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Discovery | United Kingdom | - | |
Inflammation | Discovery | United Kingdom | - | |
Neoplasms | Discovery | United Kingdom | - | |
Neoplasms | Discovery | United Kingdom | - |